BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

441 related articles for article (PubMed ID: 9726235)

  • 1. Glucose utilization and production in patients with maturity-onset diabetes of the young caused by a mutation of the hepatocyte nuclear factor-1alpha gene.
    Surmely JF; Guenat E; Philippe J; Dussoix P; Schneiter P; Temler E; Vaxillaire M; Froguel P; Jéquier E; Tappy L
    Diabetes; 1998 Sep; 47(9):1459-63. PubMed ID: 9726235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Counterregulatory responses to hypoglycemia in patients with maturity-onset diabetes of the young caused by HNF-1alpha gene mutations (MODY3).
    Guenat E; Seematter G; Philippe J; Temler E; Jéquier E; Tappy L
    Eur J Endocrinol; 2001 Jan; 144(1):45-9. PubMed ID: 11174836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin secretion and insulin sensitivity in diabetic and non-diabetic subjects with hepatic nuclear factor-1alpha (maturity-onset diabetes of the young-3) mutations.
    Vaxillaire M; Pueyo ME; Clément K; Fiet J; Timsit J; Philippe J; Robert JJ; Tappy L; Froguel P; Velho G
    Eur J Endocrinol; 1999 Dec; 141(6):609-18. PubMed ID: 10601964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contrasting insulin sensitivity of endogenous glucose production rate in subjects with hepatocyte nuclear factor-1beta and -1alpha mutations.
    Brackenridge A; Pearson ER; Shojaee-Moradie F; Hattersley AT; Russell-Jones D; Umpleby AM
    Diabetes; 2006 Feb; 55(2):405-11. PubMed ID: 16443774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel MODY3 mutations in the hepatocyte nuclear factor-1alpha gene: evidence for a hyperexcitability of pancreatic beta-cells to intravenous secretagogues in a glucose-tolerant carrier of a P447L mutation.
    Hansen T; Eiberg H; Rouard M; Vaxillaire M; Møller AM; Rasmussen SK; Fridberg M; Urhammer SA; Holst JJ; Almind K; Echwald SM; Hansen L; Bell GI; Pedersen O
    Diabetes; 1997 Apr; 46(4):726-30. PubMed ID: 9075819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. beta-cell genes and diabetes: quantitative and qualitative differences in the pathophysiology of hepatic nuclear factor-1alpha and glucokinase mutations.
    Pearson ER; Velho G; Clark P; Stride A; Shepherd M; Frayling TM; Bulman MP; Ellard S; Froguel P; Hattersley AT
    Diabetes; 2001 Feb; 50 Suppl 1():S101-7. PubMed ID: 11272165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic and clinical characterisation of maturity-onset diabetes of the young in Spanish families.
    Costa A; Bescós M; Velho G; Chêvre J; Vidal J; Sesmilo G; Bellanné-Chantelot C; Froguel P; Casamitjana R; Rivera-Fillat F; Gomis R; Conget I
    Eur J Endocrinol; 2000 Apr; 142(4):380-6. PubMed ID: 10754480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucose-mediated glucose disposal in insulin-resistant normoglycemic relatives of type 2 diabetic patients.
    Henriksen JE; Levin K; Thye-Rønn P; Alford F; Hother-Nielsen O; Holst JJ; Beck-Nielsen H
    Diabetes; 2000 Jul; 49(7):1209-18. PubMed ID: 10909980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased glibenclamide uptake in hepatocytes of hepatocyte nuclear factor-1alpha-deficient mice: a mechanism for hypersensitivity to sulfonylurea therapy in patients with maturity-onset diabetes of the young, type 3 (MODY3).
    Boileau P; Wolfrum C; Shih DQ; Yang TA; Wolkoff AW; Stoffel M
    Diabetes; 2002 Dec; 51 Suppl 3():S343-8. PubMed ID: 12475773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The pathophysiology of diabetes involves a defective amplification of the late-phase insulin response to glucose by glucose-dependent insulinotropic polypeptide-regardless of etiology and phenotype.
    Vilsbøll T; Knop FK; Krarup T; Johansen A; Madsbad S; Larsen S; Hansen T; Pedersen O; Holst JJ
    J Clin Endocrinol Metab; 2003 Oct; 88(10):4897-903. PubMed ID: 14557471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of apolipoprotein M gene expression by MODY3 gene hepatocyte nuclear factor-1alpha: haploinsufficiency is associated with reduced serum apolipoprotein M levels.
    Richter S; Shih DQ; Pearson ER; Wolfrum C; Fajans SS; Hattersley AT; Stoffel M
    Diabetes; 2003 Dec; 52(12):2989-95. PubMed ID: 14633861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preserved insulin response to tolbutamide in hepatocyte nuclear factor-1alpha mutation carriers.
    Sagen JV; Pearson ER; Johansen A; Spyer G; Søvik O; Pedersen O; Njølstad PR; Hattersley AT; Hansen T
    Diabet Med; 2005 Apr; 22(4):406-9. PubMed ID: 15787664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phenotypic characteristics of early-onset autosomal-dominant type 2 diabetes unlinked to known maturity-onset diabetes of the young (MODY) genes.
    Doria A; Yang Y; Malecki M; Scotti S; Dreyfus J; O'Keeffe C; Orban T; Warram JH; Krolewski AS
    Diabetes Care; 1999 Feb; 22(2):253-61. PubMed ID: 10333942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin secretion and insulin sensitivity in diabetic subgroups: studies in the prediabetic and diabetic state.
    Tripathy D; Carlsson AL; Lehto M; Isomaa B; Tuomi T; Groop L
    Diabetologia; 2000 Dec; 43(12):1476-83. PubMed ID: 11151756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impaired insulin secretion and increased insulin sensitivity in familial maturity-onset diabetes of the young 4 (insulin promoter factor 1 gene).
    Clocquet AR; Egan JM; Stoffers DA; Muller DC; Wideman L; Chin GA; Clarke WL; Hanks JB; Habener JF; Elahi D
    Diabetes; 2000 Nov; 49(11):1856-64. PubMed ID: 11078452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A low renal threshold for glucose in diabetic patients with a mutation in the hepatocyte nuclear factor-1alpha (HNF-1alpha) gene.
    Menzel R; Kaisaki PJ; Rjasanowski I; Heinke P; Kerner W; Menzel S
    Diabet Med; 1998 Oct; 15(10):816-20. PubMed ID: 9796880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered insulin secretory responses to glucose in diabetic and nondiabetic subjects with mutations in the diabetes susceptibility gene MODY3 on chromosome 12.
    Byrne MM; Sturis J; Menzel S; Yamagata K; Fajans SS; Dronsfield MJ; Bain SC; Hattersley AT; Velho G; Froguel P; Bell GI; Polonsky KS
    Diabetes; 1996 Nov; 45(11):1503-10. PubMed ID: 8866553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatocyte nuclear factor-1alpha modulates pancreatic beta-cell growth by regulating the expression of insulin-like growth factor-1 in INS-1 cells.
    Yang Q; Yamagata K; Fukui K; Cao Y; Nammo T; Iwahashi H; Wang H; Matsumura I; Hanafusa T; Bucala R; Wollheim CB; Miyagawa J; Matsuzawa Y
    Diabetes; 2002 Jun; 51(6):1785-92. PubMed ID: 12031966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic and clinical characteristics of maturity-onset diabetes of the young in Chinese patients.
    Xu JY; Dan QH; Chan V; Wat NM; Tam S; Tiu SC; Lee KF; Siu SC; Tsang MW; Fung LM; Chan KW; Lam KS
    Eur J Hum Genet; 2005 Apr; 13(4):422-7. PubMed ID: 15657605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Three new mutations in the hepatocyte nuclear factor-1alpha gene in Japanese subjects with diabetes mellitus: clinical features and functional characterization.
    Yoshiuchi I; Yamagata K; Yang Q; Iwahashi H; Okita K; Yamamoto K; Oue T; Imagawa A; Hamaguchi T; Yamasaki T; Horikawa Y; Satoh T; Nakajima H; Miyazaki J; Higashiyama S; Miyagawa J; Namba M; Hanafusa T; Matsuzawa Y
    Diabetologia; 1999 May; 42(5):621-6. PubMed ID: 10333057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.